![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
F Hoffmann-la Roche Ltd. Basel Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Bezafibrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 1998-124 - Rev 04
This Chemical Type CEP, issued on November 26, 2010, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1394 associated with this CEP further emphasizes